These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 26683129

  • 1. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.
    Wang HH, Portincasa P, Wang DQ.
    Eur J Clin Invest; 2016 Feb; 46(2):158-69. PubMed ID: 26683129
    [Abstract] [Full Text] [Related]

  • 2. Lack of endogenous cholecystokinin promotes cholelithogenesis in mice.
    Wang HH, Liu M, Portincasa P, Tso P, Wang DQ.
    Neurogastroenterol Motil; 2016 Mar; 28(3):364-75. PubMed ID: 26604077
    [Abstract] [Full Text] [Related]

  • 3. An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for Lith13.
    Wang HH, Portincasa P, Liu M, Tso P, Wang DQ.
    Genes (Basel); 2020 Nov 29; 11(12):. PubMed ID: 33260332
    [Abstract] [Full Text] [Related]

  • 4. Cisapride improves gallbladder contractility and bile lipid composition in an animal model of gallstone disease.
    Xu QW, Shaffer EA.
    Gastroenterology; 1993 Oct 29; 105(4):1184-91. PubMed ID: 8405865
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of gallbladder emptying decreases cholesterol saturation in bile in the Richardson ground squirrel.
    Pauletzki JG, Xu QW, Shaffer EA.
    Hepatology; 1995 Jul 29; 22(1):325-31. PubMed ID: 7601426
    [Abstract] [Full Text] [Related]

  • 6. Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice.
    Wang HH, Afdhal NH, Gendler SJ, Wang DQ.
    Gastroenterology; 2006 Jul 29; 131(1):210-22. PubMed ID: 16831603
    [Abstract] [Full Text] [Related]

  • 7. Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.
    Wang HH, Portincasa P, Wang DQ.
    Curr Med Chem; 2019 Jul 29; 26(19):3407-3423. PubMed ID: 28625150
    [Abstract] [Full Text] [Related]

  • 8. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.
    Wang HH, Portincasa P, Mendez-Sanchez N, Uribe M, Wang DQ.
    Gastroenterology; 2008 Jun 29; 134(7):2101-10. PubMed ID: 18442485
    [Abstract] [Full Text] [Related]

  • 9. Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis.
    Wang DQ, Schmitz F, Kopin AS, Carey MC.
    J Clin Invest; 2004 Aug 29; 114(4):521-8. PubMed ID: 15314689
    [Abstract] [Full Text] [Related]

  • 10. Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice.
    Wang HH, Portincasa P, Liu M, Tso P, Samuelson LC, Wang DQ.
    Biochim Biophys Acta; 2010 Feb 29; 1801(2):138-46. PubMed ID: 19836465
    [Abstract] [Full Text] [Related]

  • 11. Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization.
    Uppal H, Zhai Y, Gangopadhyay A, Khadem S, Ren S, Moser JA, Xie W.
    Hepatology; 2008 Apr 29; 47(4):1331-42. PubMed ID: 18318438
    [Abstract] [Full Text] [Related]

  • 12. Activation of Estrogen Receptor G Protein-Coupled Receptor 30 Enhances Cholesterol Cholelithogenesis in Female Mice.
    Wang HH, de Bari O, Arnatt CK, Liu M, Portincasa P, Wang DQ.
    Hepatology; 2020 Dec 29; 72(6):2077-2089. PubMed ID: 32112420
    [Abstract] [Full Text] [Related]

  • 13. Increased expression of gallbladder cholecystokinin: a receptor in prairie dogs fed a high-cholesterol diet and its dissociation with decreased contractility in response to cholecystokinin.
    Kano M, Shoda J, Satoh S, Kobayashi M, Matsuzaki Y, Abei M, Tanaka N.
    J Lab Clin Med; 2002 May 29; 139(5):285-94. PubMed ID: 12032489
    [Abstract] [Full Text] [Related]

  • 14. The deletion of the estrogen receptor α gene reduces susceptibility to estrogen-induced cholesterol cholelithiasis in female mice.
    de Bari O, Wang HH, Portincasa P, Liu M, Wang DQ.
    Biochim Biophys Acta; 2015 Oct 29; 1852(10 Pt A):2161-9. PubMed ID: 26232687
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility to murine cholesterol gallstone formation is not affected by partial disruption of the HDL receptor SR-BI.
    Wang DQ, Carey MC.
    Biochim Biophys Acta; 2002 Jul 11; 1583(2):141-50. PubMed ID: 12117558
    [Abstract] [Full Text] [Related]

  • 16. Targeted disruption of the murine mucin gene 1 decreases susceptibility to cholesterol gallstone formation.
    Wang HH, Afdhal NH, Gendler SJ, Wang DQ.
    J Lipid Res; 2004 Mar 11; 45(3):438-47. PubMed ID: 14703511
    [Abstract] [Full Text] [Related]

  • 17. Triglycerides and gallstone formation.
    Smelt AH.
    Clin Chim Acta; 2010 Nov 11; 411(21-22):1625-31. PubMed ID: 20699090
    [Abstract] [Full Text] [Related]

  • 18. Sustained gallbladder stasis promotes cholesterol gallstone formation in the ground squirrel.
    Xu QW, Mantle M, Pauletzki JG, Shaffer EA.
    Hepatology; 1997 Oct 11; 26(4):831-6. PubMed ID: 9328300
    [Abstract] [Full Text] [Related]

  • 19. Endogenous elevation of plasma cholecystokinin does not prevent gallstones.
    Shahid RA, Wang DQ, Fee BE, McCall SJ, Romac JM, Vigna SR, Liddle RA.
    Eur J Clin Invest; 2015 Mar 11; 45(3):237-46. PubMed ID: 25641074
    [Abstract] [Full Text] [Related]

  • 20. Review: pathogenesis of gallstones.
    Dowling RH.
    Aliment Pharmacol Ther; 2000 May 11; 14 Suppl 2():39-47. PubMed ID: 10903002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.